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Up to 50% of traumatic brain injury (TBI) survivors demonstrate persisting and late-onset
anxiety disorders indicative of limbic system dysregulation, yet the pathophysiology
underlying the symptoms is unclear. We hypothesize that the development of TBI-
induced anxiety-like behavior in an experimental model of TBI is mediated by changes
in glutamate neurotransmission within the amygdala. Adult, male Sprague-Dawley rats
underwent midline fluid percussion injury or sham surgery. Anxiety-like behavior was
assessed at 7 and 28 days post-injury (DPI) followed by assessment of real-time
glutamate neurotransmission in the basolateral amygdala (BLA) and central nucleus of
the amygdala (CeA) using glutamate-selective microelectrode arrays. The expression
of anxiety-like behavior at 28 DPI coincided with decreased evoked glutamate release
and slower glutamate clearance in the CeA, not BLA. Numerous factors contribute
to the changes in glutamate neurotransmission over time. In two additional animal
cohorts, protein levels of glutamatergic transporters (Glt-1 and GLAST) and presynaptic
modulators of glutamate release (mGluR2, TrkB, BDNF, and glucocorticoid receptors)
were quantified using automated capillary western techniques at 28 DPI. Astrocytosis
and microglial activation have been shown to drive maladaptive glutamate signaling and
were histologically assessed over 28 DPI. Alterations in glutamate neurotransmission
could not be explained by changes in protein levels for glutamate transporters, mGluR2
receptors, astrocytosis, and microglial activation. Presynaptic modulators, BDNF and
TrkB, were significantly decreased at 28 DPI in the amygdala. Dysfunction in presynaptic
regulation of glutamate neurotransmission may contribute to anxiety-related behavior
and serve as a therapeutic target to improve circuit function.
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HIGHLIGHTS
- A single diffuse brain injury induces anxiety-like behavior in
an open field environment.
- Altered glutamate neurotransmission occurs following diffuse
TBI in the CeA, but not in the BLA.
- The expression of affective symptoms coincides with altered
glutamate neurotransmission in the CeA.
- Altered glutamate neurotransmission occurs in the absence of
overt neuropathology and gliosis.
- BDNF and TrkB were significantly decreased at 28 DPI in
the amygdala.
INTRODUCTION
Affective disorders, including generalized anxiety disorder and
post-traumatic stress disorder (PTSD), develop and persist in
up to 50% of traumatic brain injury (TBI) survivors, however,
few common biological mechanisms between TBI and non-TBI
patients have been elucidated (Kessler et al., 2005; Scholten et al.,
2016). The incidence of TBI continues to rise, with at least
2.5 million Americans reporting a TBI each year, costing the
American health care system 76.5 billion dollars (Hyder et al.,
2007; Coronado et al., 2012). Three-quarters of all TBIs are
diffuse TBIs (dTBI) in which the signature pathology is multi-
focal diffuse axonal injury with no overt pathology detected
by CT or MRI (Lee and Newberg, 2005; Grossman et al.,
2010; Liu et al., 2014). dTBI subsequently induces secondary
sequelae that occur seconds to months following the initial injury,
leading to the development of affective, cognitive, and somatic
symptoms (McAllister, 1992; Masel and DeWitt, 2010). Despite
clinical prevalence, the pathophysiology contributing to affective
symptoms following dTBI is poorly understood, resulting in
misdiagnosis and ineffective treatments (Van der Kolk, 2002;
Collins et al., 2004; Hoge et al., 2014). Ultimately, ineffective
treatment impacts a patient’s ability to return to work, daily
function, and social interactions; severely impairing the quality
of life for both the patient and caregivers (Trahan et al., 2001;
Guerin et al., 2006; van der Horn et al., 2013).
Clinical and preclinical data demonstrate that dTBI causes
profound lasting changes in the amygdala. In Veterans, early
amygdala fMRI reactivity post-injury is predictive of the
development of PTSD and could contribute to the bilateral
reduction of amygdala size observed in patients diagnosed with
both TBI and PTSD (Depue et al., 2014; Stevens et al., 2016).
A study in collegiate football players report a positive correlation
between amygdala shape and mood states (Cho et al., 2018).
TBI survivors with major depressive disorder had smaller lateral
and dorsal prefrontal cortex, which mediates ventral-limbic
and paralimbic pathways and influences amygdala circuitry
(Jorge et al., 2004). Preclinically, diffuse and focal experimental
models of TBI also identify alterations in amygdala circuitry,
including increased neuronal hyperexcitability and GABA
production proteins in the absence of overt neuropathology
(Hallam et al., 2004; Meyer et al., 2012). In addition, pyramidal
and stellate neurons in the basolateral amygdala (BLA)
demonstrate increased complexity distal and proximal to the
soma as early as 1 day post-injury (DPI) and persisting until at
least 28 DPI indicating BLA- central nucleus of the amygdala
(CeA) circuit reorganization after dTBI (Hoffman et al., 2017).
Together, these data indicate that TBI-induced changes to the
amygdala and associated limbic system circuitry could contribute
to the development of affective disorders following injury.
Limbic system circuitry influences affective symptoms with
evidence that glutamatergic neurons originating in the BLA
and projecting into the CeA play a critical role in mediating
anxiety-like behavior (Swanson and Petrovich, 1998; Tye et al.,
2011; Janak and Tye, 2015; Babaev et al., 2018). BLA neurons
are 90% glutamatergic, highlighting the role of glutamate
neurotransmission in displays of affective behavior (Carlsen,
1988; Smith and Pare, 1994). Glutamate neurotransmission is
regulated by astrocytes and microglia processes surrounding
the synapse (Murugan et al., 2013). Glutamate transporters,
Glt-1 and GLAST (located on astrocytes), rapidly remove
glutamate from the extracellular space, restricting glutamate to
the synaptic cleft (Danbolt, 2001; Pal, 2018). When spillover
does occur, feedback through the metabotropic glutamate
receptor 2 (mGluR2) can reduce presynaptic release of glutamate
(Loane et al., 2012). Decreased levels of brain derived
neurotropic factor (BDNF), tropomyosin-related kinase B (TrkB)
receptors, and glucocorticoid receptors (GluR) – commonly
reported with affective disorders – have also been reported
to attenuate presynaptic glutamate release (Numakawa et al.,
2009; Chiba et al., 2012; Meis et al., 2012). Each of these
molecular components contribute to the complex regulation
of glutamatergic neurotransmission and work to maintain
homeostatic communication.
We hypothesize that TBI-induced anxiety-like behavior is
mediated by changes in glutamate neurotransmission within
the amygdala. In a well-established model of dTBI that causes
diffuse axonal injury (DAI) in rats, we assessed the expression
of anxiety-like behavior at 1-week and 1-month post-injury
using open field testing (OFT). Immediately following OFT, in
vivo amperometric recordings in the BLA and CeA evaluated
glutamate clearance kinetics and available glutamate stores as an
indicator of disrupted glutamate neurotransmission. Pathological
and molecular analyses of nuclei-specific changes were used
to identify future therapeutic targets to mediate glutamate
neurotransmission associated with amygdala circuit function.
MATERIALS AND METHODS
Animals
A total of 69 adult, male Sprague-Dawley rats (weights 279–420
grams; age 3–4 months) (Envigo, Indianapolis, IN, United States)
were used in these experiments. (29 rats for amperometry, 22
for histology, and 18 rats for protein assays). Upon arrival,
rats were given a 1-week acclimation period, housed in normal
12-h light/dark cycle (Red light: 18:00 to 06:00) and allowed
access to food and water ad libitum (Teklad 2918, Envigo,
Indianapolis, IN). Rats were pair housed according to injury
status (i.e., injured housed with injured) throughout the duration
Frontiers in Neuroscience | www.frontiersin.org 2 January 2020 | Volume 13 | Article 1434
fnins-13-01434 January 11, 2020 Time: 11:34 # 3
Beitchman et al. TBI Induces Chronic Amygdala Dysfunction
of the study. All procedures and animal care were conducted
in compliance with an approved Institutional Animal Care
and Use Committee Protocol (13–460) at the University of
Arizona College of Medicine-Phoenix which is consistent with
the National Institutes of Health (NIH) Guidelines for the Care
and Use of Laboratory Animals.
Rats undergoing open field testing (OFT) were exposed to
human contact and handled for a total of 50 min over a period
of 7 days. Rats aged out to 28 DPI received an additional 30 min
of handling by the same investigator over a period of 3 days
immediately prior to testing to reacclimate to human contact.
Handling of rats ensures that the response to the behavioral
paradigm is not confounded by the threat of investigator
handling (Costa et al., 2012). At 7/8 DPI or 28/29 DPI,
injured and sham rats underwent OFT between 07:00 and 09:00,
immediately followed by in vivo amperometric recordings by
the handling investigator. Time of day and timing between OFT
and recordings were held constant throughout all experiments
to account for any potential influence of diurnal corticosterone
levels and lasting molecular and structural influences from
behavior (OFT)-induced stress responses (Zhang et al., 2018).
For the remainder of the manuscript, DPI for the amperometric
and behavioral outcome measures at 7/8 and 28/29 DPI will be
abbreviated as 7 DPI and 28 DPI. For behavioral analysis and
subsequent amperometric recordings, a total of 17 rats were aged
to the 1-week time point (11 injured; 6 sham) and 17 rats were
aged to 1-month (10 injured; 7 sham), based on a priori power-
calculations from previous electrochemical experiments (Thomas
et al., 2012) (experimental design; Figure 1A).
Midline Fluid Percussion Injury (mFPI)
Surgical Procedure
Midline FPI surgery was carried out similarly to previously
published methods from this laboratory by an investigator who
was not the handler (Thomas et al., 2012). Rats were randomized
into either injured or sham groups following acclimation to
the vivarium facility and exposure to human contact. Briefly,
rats were anesthetized with 5% isoflurane in 21% O2 and
placed into a stereotaxic frame (Kopf Instruments, Tujunga,
CA, United States) with a nose-cone that maintained 2.5%
isoflurane for the duration of the procedure. A 4.8 mm circular
craniotomy was centered on the sagittal suture midway between
bregma and lambda carefully ensuring that the underlying
dura and superior sagittal sinus were not disturbed. An injury
hub created from the female portion of a 20-gauge Luer-Loc
needle hub was cut, beveled and placed directly above and
in-line with the craniectomy site. A stainless-steel anchoring
screw was then placed into a 1 mm hand-drilled hole into
the right frontal bone. The injury hub was affixed over the
craniectomy using cyanoacrylate gel and methyl-methacrylate
(Hygenic Corp., Akron, OH, United States) and filled with 0.9%
sterile saline. The incision was then partially sutured closed
on the anterior and posterior edges with 4.0 Ethilon sutures
and topical lidocaine and antibiotic ointment were applied. Rats
were returned to a warmed holding cage and monitored until
ambulatory (approximately 60–90 min).
Injury Induction
Approximately 24 h following surgical procedures and the return
of ambulation, rats were re-anesthetized. The hub was filled
with 0.9% sterile saline and attached to the male end of a fluid
percussion device (Custom Design and Fabrication, Virginia
Commonwealth University, Richmond, VA, United States). After
return of the pedal withdrawal reflex, an injury averaging
2.19 atm was administered by releasing the pendulum (16.5
degrees) onto the fluid-filled cylinder. Shams were attached
to the fluid percussion device, but the pendulum was not
released. Immediately after the administration of injury, the
injury hub was removed en bloc and rats monitored for
the presence of apnea, fencing response, and the return
of righting reflex. Then, rats were briefly re-anesthetized to
inspect the injury site for hematoma, herniation, and dural
integrity. The injury site was then stapled closed and topical
lidocaine and antibiotic ointment were applied. Inclusion
criterion required that injured rats have a righting reflex
time ranging from 5 to 12 min (average 7:43 ± 0:07 min)
and a fencing response (McIntosh et al., 1987; Hosseini and
Lifshitz, 2009). After regaining the righting reflex, rats were
placed in a clean, warmed holding cage, and monitored
for at least 1 h following injury before being returned to
the vivarium where post-operative evaluations continued for
3 DPI. Staples for rats with a 28-day time point were
removed at 7 DPI.
Midline fluid percussion injury in rats have been used
for over 25 years, predominantly in the Sprague-Dawley
strain. Reproducible pathophysiological and behavioral responses
relevant to clinical data have been published (Riess et al.,
2002; Thompson et al., 2005; Witgen et al., 2005; Lifshitz
et al., 2007; Hosseini and Lifshitz, 2009; Hall and Lifshitz,
2010; McNamara et al., 2010; Alder et al., 2011; Cao et al.,
2012; Learoyd and Lifshitz, 2012; Lifshitz and Lisembee, 2012;
Thomas et al., 2012; Rowe et al., 2013, 2014; Harrison et al.,
2014, 2015; Fenn et al., 2015). mFPI best models closed head
injury with decompressive craniectomy by reproducing diffuse
axonal injury without contusion or cavitation encompassing the
hallmark pathology of clinical diffuse TBI. While craniectomy
is a procedure often carried out in more severe clinical
cases in which cerebral herniation is a concern, it provides
control of increased intracranial pressure here, which when
unregulated can induce a more severe injury with worse
outcome (Lafrenaye et al., 2014). After regaining reflexive
responses (5–12 min), injured rats require little to no medical
intervention in the post-operative period, most similar to
mild TBI as defined by a Glasgow Coma Score of 13–15.
A more detailed discussion in the clinical relevance of
mFPI can be found in our recently published review article
(Lifshitz et al., 2016).
Open Field Testing
To evaluate for the presence of the development of affective
behaviors following diffuse TBI as modeled by mFPI, an open
field analysis was performed. Each rat was placed into the
center of a novel black open field (measuring 69 cm × 69 cm)
facing the same direction at least 1 h following the light
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FIGURE 1 | dTBI induces the expression of anxiety-like behavior. (A) Study design for behavioral and amperometry studies. (B) Representative video tracking data
from Ethovision R© software during the first 5 min of open field testing from sham. (C) Representative video tracking data from Ethovision R© software during the first
5 min of open field testing from 28 DPI rats. (D) Distance traveled is similar between 7 DPI, 28 DPI, and sham [One-Way ANOVA F (2,29) = 3.23; p = 0.05]. (E)
28 DPI rats spent significantly less time in the center of the open field [Kruskal-Wallis H = 6.711; p < 0.05; Dunn’s post hoc comparison p < 0.05; Mann-Whitney U
post hoc p < 0.05, r = 0.48]. (F) 28 DPI rats made significantly fewer entries into the center of the open field when compared to sham [Kruskal-Wallis H = 6.83;
p < 0.05; Dunn’s post hoc comparison p < 0.05; Mann-Whitney U post hoc p < 0.05, r = 0.46]. Bar graphs represents mean ± SEM. n = 10–12 for each group.
*p < 0.05 in comparison to sham.
cycle change from red to white light. White overhead lights
ensured equal illumination throughout the container for a
total of 15 min. Ambient white noise (60–70 decibels) in the
room mitigated any variation in noise levels. Tracking was
accomplished by Ethovision R© Software which mapped the rat
directly overhead. Two regions were defined using Ethovision R©,
separating the open field into an outer region and an inner
region (35 cm × 35 cm). Time spent in each zone was calculated
based on the center-point of the rat. Primary outcome measures
analyzed total distance traveled, time spent in the center, and
entries to the center of the open field for the first 5 min
of the task to be more representative of anxiety-like behavior
(Gould et al., 2009).
Electrochemistry
Enzyme-Based Microelectrode Arrays
Ceramic-based microelectrode arrays (MEA) encompassing four
platinum (Pt) recording surfaces (15 µm × 333 µm) aligned in
a dual, paired configuration were prepared to measure glutamate
for in vivo anesthetized recordings (S2 configuration; Quanteon,
Nicholasville, KY, United States). MEAs were fabricated, selected
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for recordings, and made glutamate sensitive as previously
described (Thomas et al., 2012, 2017). Briefly, Pt sites 1 and 2 were
coated with a solution containing glutamate oxidase (GluOx),
bovine serum albumin (BSA), and glutaraldehyde, enabling these
sites to selectively detect glutamate levels with low limits of
detection (Nickell et al., 2005). Pt sites 3 and 4 were coated with
only BSA and glutaraldehyde and served as sentinels, recording
everything channels 1 and 2 recorded except for glutamate
(Burmeister and Gerhardt, 2001). Prior to calibration and in
vivo recordings, all four Pt recording sites were electroplated
with a size exclusion layer of 1,3-phenylendediamine (mPD)
(Acros Organics, Morris Plains, NJ, United States). GluOx
converts glutamate into α-ketoglutarate and peroxide (H2O2).
The H2O2 functions as a reporter molecule, traversing the mPD
layer and is readily oxidized and recorded as current using
the FAST-16 mkIII system (Fast Analytical Sensor Technology
Mark III, Quanteon, LLC, Nicholasville, KY, United States)
(Supplementary Figure S1).
Microelectrode Array Calibration
On the morning of in vivo recordings, each MEA was calibrated
in vitro to determine recording parameters: slope (sensitivity to
glutamate), limit of detection (LOD; lowest amount of glutamate
to be reliably recorded), and selectivity (ratio of glutamate to
ascorbic acid). For calibration, aliquots from stock solutions were
added to 40 mL of 0.05 M phosphate buffered saline (PBS)
(pH 7.1–7.4; stirring; 37◦C) in the following sequence: 500 µL
of 20 mM ascorbic acid, three additions of 40 µL of 20 mM
l-glutamate, and 40 µL of 8.8 mM H2O2 to produce a final
concentration of 250 µM AA, 20, 40, and 60 µM glutamate,
and 8.8 µM H2O2. A representative MEA calibration is shown
in Figure 2A. For the study, a total of 48 MEAs were used
with a total of 91 recording sites. Additionally, there was an
overall average slope of 6.9 pA/µM, a LOD of 2.4 µM, and a
selectivity of 44 to 1.
Microelectrode Array/Micropipette Assembly
Following calibration, a single micropipette was attached to
the MEA using the following steps to allow for the local
application of solutions during in vivo experiments. A single-
barreled glass capillary with filament (1.0 mm × 0.58 mm, 6”
A-M Systems, Inc., Sequim, WA, United States) was pulled using
a Kopf Pipette Puller (David Kopf Instruments, Tujunga, CA,
United States). Using a microscope with a calibrated reticle,
the pulled micropipette was bumped against a glass rod to
have an inner diameter of 7–13 µm (10.5 µm ± 0.2). Clay
was used to place the tip of the micropipette between the 4
Pt recording sites. This alignment was secured using Sticky
Wax (Kerr Manufacturing Co). The final measurements were
the distance between the micropipette tip and the MEA surface
(72 ± 3 µm) and the distance between the micropipette tip and
the MEA tip (498± 4 µm).
Surgery for Amperometric Recordings
Immediately after OFT, sham and brain-injured rats were
anesthetized with three or four intraperitoneal injections of 25%
urethane in 15-min intervals (1.5 g/Kg; Sigma Aldrich, St. Louis,
MO, United States). Following cessation of a pedal withdrawal
reflex, each rat was then placed into a stereotaxic frame (David
Kopf Instruments) with non-terminal ear bars. Body temperature
was maintained at 37◦C with isothermal heating pads (Braintree
Scientific, Braintree, MA, United States). A midline incision
was made and the skin, fascia, and temporal muscles were
reflected to expose the skull. A bilateral craniectomy exposed
the stereotaxic coordinates for the BLA and CeA. Dura was then
removed prior to the implantation of the MEA. Brain tissue was
kept moist through the application of saline soaked cotton balls
and gauze. Finally, using blunt dissection, an Ag/AgCl coated
reference electrode wire was placed in a subcutaneous pocket
on the dorsal side of the subject (Moussy and Harrison, 1994;
Quintero et al., 2007).
In vivo Amperometric Recording
Amperometric recordings performed here were done similar
to previous published methods (Hinzman et al., 2010; Thomas
et al., 2012). Briefly, a constant voltage was applied to the MEA
using the FAST-16 mkIII recording system. In vivo recordings
were performed at an applied potential of +0.7 V compared
to the Ag/AgCl reference electrode. All data were recorded at
a frequency of 10 Hz, amplified by the headstage (2 pA/mV)
without signal processing or filtering of the data.
Immediately prior to implantation of the MEA, the pipette
was then filled with 120 mM KCl (120 mM KCl, 29mM NaCl,
2.5mM CaCl2 in ddH2O, and pH 7.2 to 7.5) or 100 µM
l-glutamate (100 µM l-glutamate in 0.9% sterile saline pH 7.2–
7.6). Concentrations for both solutions have been previously
shown to elicit reproducible KCl-evoked glutamate release or
exogenous glutamate peaks (Burmeister et al., 2002; Thomas
et al., 2012). Solutions were filtered through a 0.20 µm sterile
syringe filter (Sarstedt AG & Co., Numbrecht, Germany) and
loaded into the affixed micropipette using a 4-inch, 30-gauge
stainless steel needle with a beveled tip (Popper and Son, Inc,
NY, United States). The open end of the micropipette was
connected to a Picospritzer III (Parker-Hannin Corp., General
Valve Corporation, Mayfield Heights, OH, United States) with
settings to dispense nanoliter quantities of fluid over a 1 s
period using the necessary pressure of nitrogen (inert) gas
using a dissecting microscope (Meiji Techno, San Jose, CA,
United States) with a calibrated reticle in the eyepiece (Cass et al.,
1992; Friedemann and Gerhardt, 1992).
The MEA-micropipette was localized in the BLA
(A/P: ± 2.4 mm; M/L: ± 5.1 mm; D/V: −8.0 mm) and
CeA (A/P: −2.4 mm; M/L: ± 3.9 mm; D/V: −8.0 mm) using
coordinates from George Paxinos and Charles Watson Rat
Brain Atlas (6th Edition) through use of the Dual Precise Small
Animal Stereotaxic Frame (Kopf, model 962). Glutamate and
KCl-evoked measures were recorded in both hemispheres in
a randomized and balanced experimental design to mitigate
possible hemispheric variations or effect of anesthesia duration.
KCl-Evoked Release of Glutamate Analysis
Parameters
Once the electrochemical signal had reached baseline, 120 mM
KCl was locally applied (BLA: 110 ± 8 nl; CeA: 105 ± 4 nl)
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FIGURE 2 | TBI induces altered glutamate neurotransmission in the CeA. (A) Representative calibration of glutamate selective MEA. Arrows represent aliquots of
solution of either 250 µM ascorbic acid (AA), 20 µM glutamate (Glu), or 8.8 µM H2O2. (B) Calculations for total evoked glutamate release following local applications
of 120 mM potassium chloride solution (KCl). (C) Calculations for extracellular clearance of glutamate following local applications of 100 µM glutamate. (D) No
significant differences were observed in evoked glutamate release in the BLA [Kruskal Wallis H = 4.63; p = 0.10; n = 8–11]. (E) No changes in glutamate clearance
were observed when assessing the uptake rate [One-way ANOVA F (2,21) = 1.24; p = 0.31] or (F) T80 [One-way ANOVA F (2,21) = 0.14; p = 0.87; n = 6–10]. (G)
Representative traces of KCl-evoked glutamate release. Baseline levels have been adjusted to show comparison amongst the three time points. Arrow represents
120 mM KCl administration. (H) 28 DPI rats had 50% less total evoked glutamate when compared to shams [One way ANOVA F (2,19) = 4.74 p < 0.05 Dunnett’s
post hoc p < 0.05, η2 = 0.33; n = 6–9] in the CeA. (I) Representative traces of extracellular glutamate clearance. Baselines levels have been adjusted to show
comparison amongst the three time points. Arrow represents 100 µM glutamate administration. (J) 7 and 28 DPI rats had 40% and 58% slower uptake rate,
respectively [One-way ANOVA F (2,22) = 7.88; p < 0.01, @ 7 DPI Dunnett’s post hoc p < 0.05, @ 28 DPI Dunnett’s post hoc p < 0.01, η2 = 0.41; n = 7–10]. (K)
28 DPI rats had a 43% increase in T80 [One-way ANOVA F (2,22) = 5.00; p < 0.05, Dunnett’s post hoc p < 0.01, η2 = 0.33; n = 7–10]. (L) Uptake rate remained
consistent between subsequent additions of glutamate to the CeA [RM Two-way ANOVA F (2,21) = 8.16; p < 0.01; n = 7–10]. Bar graphs represents mean ± SEM.
*p < 0.05 in comparison to sham.
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to produce an evoked glutamate release. Additional ejections
of KCl were completed at 2-min intervals and were volume
matched at the time of administration. Criteria for analysis
required that the peak with the largest amplitude was acquired
from the first local application of KCl. This ensured that
the data chosen were most representative of the maximum
glutamate released within the surrounding neuronal tissue.
Primary outcome measures were area under the curve as a proxy
to investigate the total glutamate release capable of the recorded
region. For a diagrammatic representation of these calculations,
see Figure 2B.
Glutamate Clearance Analysis Parameters
Once the baseline was reached and maintained for at least
2 min (10–20 min), 100 µM glutamate was locally applied into
the extracellular space (BLA: 73 ± 17 nl; CeA: 78 ± 15 nl).
Exogenous glutamate was released at 30 s intervals and amplitude
was matched at the time of administration. In analysis, three
peaks were selected based on a predetermined amplitude range
of 15 to 25 µM to ensure that data chosen were most
representative of the glutamate clearance of similar volume
and amplitude in accordance with Michaelis-Menton kinetics
clearance parameters. The parameters for the 3 peaks were then
averaged to create a single representative value per recorded
region per rat. Primary outcome measures analyzed the uptake
rate and the time taken for 80% of the maximum amplitude of
glutamate to clear the extracellular space (T80). The uptake rate
was calculated using the uptake rate constant (k−1) multiplied
by the peak’s maximum amplitude, thus controlling for any
variation between the amount of applied glutamate between
peaks. For a diagrammatic representation of these calculations,
see Figure 2C.
MEA Placement Verification
Immediately following in vivo anesthetized recordings, rats
were transcardially perfused with PBS followed directly by
4% paraformaldehyde (PFA). Brains were cryoprotected and
sectioned at 40 µm sections to confirm MEA electrode
placement. Of these, 1.96% of electrode tracts were excluded
due to inaccurate placement. Representative image shown in
Supplementary Figure S2.
Microglia Skeleton Analysis
At 1, 7, and 28 DPI, sham and brain-injured rats (n = 3/time
point) were administered a lethal dose of Euthasol R© (a
sodium pentobarbital mixture, 200 mg/kg, i.p., Virbac AH,
Inc.) and were transcardially perfused with PBS, followed by
a fixative solution containing 4% paraformaldehyde. Brains
were then shipped to Neuroscience Associates Inc (Knoxville,
TN) where they were embedded into a single gelatin block
(MultiBrain R© Technology, NeuroScience Associates, Knoxville,
TN, United States). Forty-micron thick sections were taken
in the coronal plane and wet-mounted on 2%-gelatin-subbed
slides before being stained with ionized calcium binding adaptor
molecule (Iba1) primary antibody and 3,3′-Diaminobenzidine
(DAB) visualization (NeuroScience Associates, Knoxville, TN,
United States) to identify all microglia. Images and analysis
of alternate regions of the same histology (for all NSA
tissue) has been previously described (Cao et al., 2012;
Lifshitz and Lisembee, 2012; Miremami et al., 2014; Rowe
et al., 2016; Hoffman et al., 2017; Morrison et al., 2017;
Thomas et al., 2018).
Photomicrographs of the BLA and CeA were taken using
a Zeiss microscope (Imager A2; Carl Zeiss, Jena, Germany) in
bright-field mode with a digital camera using a 40× objective.
One digital photomicrograph in each region was acquired from
the left and right hemisphere, respectively, for each time point
across three coronal sections for each mFPI and sham rat,
for a total of 6 images per rat. A computer-aided skeletal
analysis method was used to quantify morphological remodeling
of ramified microglia after experimental diffuse brain injury
(Young and Morrison, 2018).
Skeleton Analysis
Microglia were analyzed by an investigator blinded to
injury status using computer-aided skeleton analysis as
previously published (Young and Morrison, 2018). Briefly,
photomicrographs were converted to binary images which
were skeletonized using ImageJ software (National Institutes
of Health1) (Supplementary Figure S3). The Analyze Skeleton
Plugin (developed by and maintained here2) was applied to
the skeletonized images, which tags branches and endpoints
and provides the total length of branches and total number
of endpoints for each photomicrograph. Cell somas were
manually counted by 2 investigators and averaged for each
photomicrograph. The total branch length and number of
process endpoints were normalized to number of microglia cell
somas per image. Data from the 6 images were averaged to a
single representative measure per animal.
GFAP Analysis
At 7 and 28 DPI, injured and sham rats were given a lethal
dose of Euthasol R© and transcardially perfused with 4% PFA/PBS
(sham = 3, 7 DPI = 3, 28 DPI = 4). The brains were then
cryoprotected in graded sucrose solutions (15% and 30%)
and cryosectioned (20 µm). Sections were prepared exactly as
previously described using rabbit anti-GFAP primary antibody
(1:1000; Dako, catalog# Z0334) and biotinylated horse anti-rabbit
secondary antibody (1:250; Vector Laboratories, Burlingame,
CA, United States; Catalog#Ba-1100) then incubated with DAB
(Rowe et al., 2016; Hoffman et al., 2017). The sections were
dehydrated with ethanol and cleared in citriSolv before being
cover-slipped with DPX.
Montaged images encompassing both hemispheres were
taken using a Zeiss microscope (Imager A2; Carl Zeiss,
Jena, Germany) in bright-field mode with a digital camera.
Quantitative analysis was performed using ImageJ Software
(3.1.1v, NIH, Bethesda, MD, United States) on a Macintosh
computer (OSX 10.11.6). The CeA was identified and traced
based on topographical localization to the optic chiasm, rhinal
fissure, and commissural stria terminalis. Grayscale digital images
1https://imagej.nih.gov/ij/
2http://imagej.net/AnalyzeSkeleton31
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were then digitally thresholded to separate positive-stained
pixels from unstained pixels. The percentage of argyrophilic
(black) stained pixels was calculated for each image using the
following formula:
Total area measured black/Total area measured× 100
= Percentage area with argyrophilic stain
Five to six rat brain hemispheres were analyzed per rat (n = 3–
4/time point), depending on the quality of the section mounted
(no folds or tearing within the area of interest). The same image
was analyzed three times. The standard deviation between the
percent area black was below 10% within each rat.
deOlmos Silver Stain Analysis
Alternating sections of brains prepared by NeuroScience
Associates Inc (Knoxville, TN, United States) (see Iba1
staining methods; Thomas et al., 2018) were cryosectioned,
mounted, stained using de Olmos aminocupric silver
technique, counterstained with Neutral Red, and cover-slipped.
Densitometric quantitative analysis was performed identical to
GFAP analysis. Four hemispheres per rat (n = 3/time point)
were analyzed and each hemisphere was analyzed three times.
These 12 statistical numbers indicating the percentage of black
pixels were then averaged together to a single value (per rat) and
subsequently used in statistical analysis. The standard deviation
between the percent area black was below 10% within each rat.
Tissue Dissection and Protein Extraction
At 28 DPI, a new cohort of rats (n = 5/each) were given a lethal
dose of Euthasol R©. Animals were transcardially perfused with
ice-cold PBS for 3 min. The brain was rapidly removed and
rinsed with ice-cold PBS. Tissue biopsies (1 mm diameter) taken
bilaterally from the BLA and CeA were collected from 2 mm
thick coronal sections made using a chilled rat brain matrix.
Tissue biopsies were flash frozen and stored at −80◦C until
protein was extracted for automated capillary western analysis.
Total protein was extracted from the BLA and CeA previously
stored at−80◦C. Tissues were homogenized in 250 µl of ice-cold
extraction buffer (pH 8.0) containing 0.24 M Tris, 0.74 M NaCl,
100 µl TritonX100 with a protease inhibitor cocktail (complete,
Roche Diagnostics; #11836153001). Tissue was homogenized
with the Precellys R©24 machine (Bertin Technologies, Montigny
le Bretonneux, France) for 40 s bouts until the solution was
completely clear (being chilled on iced for 2 min between bouts).
Samples were then centrifuged at 3,000 × g for 15 min and the
supernatant stored in 10–20 µl aliquots at −80C until analysis.
Protein concentrations were determined using the bicinchoninic
acid assay (BCA) following manufacturer’s instructions (Pierce,
Rockford, IL, United States).
Automated Capillary Western – ProteinSimple (Wes)
Protein expression was evaluated using automated capillary
western (ProteinSimpleTM, Biotechne, San Jose, CA,
United States). Experiments were run per manufacturer’s
instructions and using products purchased through
ProteinSimpleTM (unless otherwise noted), including 12–
230 kDA capillary cartridges (SM-W004) and anti-rabbit
detection modules (DM001). Proprietary mixtures included a
biotinylated ladder and molecular weight standards as internal
controls. Technical properties of the Simple WesternTM are
described by Rustandi et al. and Loughney et al. (2014). Prior
to experiments, optimization was carried out for protein
concentration, primary antibody concentration, multiplexing
with a biological control (GAPDH), denaturing process, and
exposure time (Supplementary Table S1). Target protein
concentration was chosen within the midpoint of the slope
(0.125–2.5 µg/capillary). Antibody concentration was based
on evidence of antigen saturation at the chosen protein
concentration. Target and GAPDH (loading control) were
optimized for multiplexing to ensure chemiluminescence was
within systems threshold and to ensure no protein-protein
interactions. If chemiluminescent detection was above the
threshold, secondary antibodies from Jackson ImmunoResearch
Laboratories, Inc (West Grove, PA, United States) were used
to dilute the manufacturer’s secondary antibody to reduce
amplification of highly expressed targets (Goat Anti-Rabbit
111-005-045, HRP-Goat Anti-Rabbit 111-035-045, Goat Anti-
Mouse 115-005-062, and HRP-Goat Anti-Mouse 115-035-062).
Denaturing temperature was chosen based on low signal to
noise and baseline. The high-dynamic range of the exposures
(algorithm in software) was used for data analysis in all
experiments. Every capillary cartridge (25 capillaries) was run
with the following controls: the same brain homogenate as
a positive control, Erk as a system control, Antibody only,
and protein only.
Protein extracts from amygdala samples were combined
with sample buffer and master-mix (40 mM DTT, 0.1×
ProteinSimple Sample Buffer, and 1× Fluorescent Standards)
to achieve the desired protein concentration. Samples were
then denatured via heating block at the optimized temperature
(37◦C × 30 min). Duplicate capillaries of each sample
were loaded per manufacturer’s instructions, the cartridge
was centrifuged at 2500 RPM for 5 min, and placed into
the automated capillary western machine where proteins
were separated by size (electrophoresis), immobilized, and
immunoprobed in individual capillaries. Once loaded into the
instrument, the standard default metrics recommended by
ProteinSimple were utilized for separation, incubation, and
detection. The associated software, Compass (ProteinSimple R©),
generates an electropherogram with peaks corresponding to the
expression of proteins of interest and calculates the area under
the curve (AUC) for each peak (Figure 4E). To calculate relative
protein expression, the AUC for the protein was normalized to
the AUC for the biological control (GAPDH). The ratios from
duplicate capillaries were averaged. Then, ratios from injured
animals were normalized to shams in the same capillary cartridge.
Statistical Analysis
Based on KCl-evoked glutamate release in the thalamus from
a previous publication by Thomas et al (Thomas et al., 2012),
3–12 rats per group could detect a 100% increase in evoked
glutamate release at 80% power at a significance level of 0.05
on a 2-sided test. Statistical analysis was determined by a priori
planned comparisons, where our primary outcome measure
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(OFT, electrochemistry, histology, protein levels) was to detect
changes between 7 DPI or 28 DPI and shams. All data were
analyzed using a customized Microsoft Excel R© spreadsheet and
GraphPad R© software. Seven day and 28 day shams did not
statistically differ from one another for all outcomes of behavior
(e.g., time in center: 7D sham 31.3± 7.2 s, 28D sham 34.7± 6.7 s)
and electrochemical measures (e.g., evoked glutamate release
(AUC): BLA-7D sham 105.9 ± 33.9, 28D sham 119.1 ± 20.8;
and CeA-7D sham 136.4 ± 34.2 and 140 ± 23.6). Therefore,
7D and 28D shams were combined for statistical analysis. When
ANOVA assumptions were met and the dependent variable was
continuous, data were analyzed using a one-way ANOVA with
Dunnet’s post hoc comparison to sham. All data were assessed
for normality and variability. Data not passing Shapiro-Wilks
normality tests or Brown-Forsythe variability test were analyzed
as non-parametric statistics with a Kruskal-Wallis (KW) analysis
and Dunn’s post hoc comparison to sham. Outliers in the open
field test were determined using three standard deviations from
the mean. Using these metrics, two rats were excluded from
consideration (7-day sham, 7 DPI). Amperometric measures
from the paired MEA recording sites for each outcome in each
region were averaged and used as a single data point. Outliers
for amperometric analysis were determined using a ROUT test
with Q = 5% (BLA = 1 of 28; CeA = 4 of 28). Additional analysis
of extracellular clearance of glutamate in the CeA assessing
for the potential effects of multiple additions of glutamate and
differential effects of nuclei-specific microglial activation were
conducted with a two-way ANOVA with a Tukey comparison.
To be included in the amperometric recordings, the rat had
to be included in the in open field testing. Molecular data for
glutamate transporters were analyzed using an unpaired, two-
tailed Student’s t-test. Based on our hypothesis of a decrease
in protein levels for BDNF, TrkB, and GluR, we used a one-
tailed Student’s t-test. For all instances, statistical significance was
defined at p < 0.05.
Effect Size
For parametric calculation using the one-way ANOVA, eta
squared η2 was conducted as described by Lakens (2013). η2 was
evaluated and reported such that 0.02 represents a small effect
size, 0.13 represents a medium effect size and 0.16 represents
a large effect size. Data comparing two means and analyzed
using a Student’s t-test were evaluated using Cohen’s d. For non-
parametric calculations using the Kruskal-Wallis test, Pearson’s
r was reported as described by Fritz et al. (2012). To do so, a
Mann Whitney U post hoc comparison was done between the two
groups identified to have a difference as indicated by the Dunn’s
post hoc comparison. Then a Pearson’s r effect size calculation
was evaluated and reported such that a 0.1 equals a small effect
size, 0.3 represents a medium effect size and 0.5 represents a
large effect size.
Data Analysis Validation
All outcome measures were evaluated for variability based on
cohort membership, cage-mates, cage changes, time/order of
open field testing, and time of recordings. Of these, no variables,
other than injury status, could explain the variation observed in
the presented data sets.
RESULTS
dTBI Induces the Expression of
Anxiety-Like Behavior
Representative traces of first 5 min of open field exploration
illustrate behavioral performance between brain-injured and
sham rats (Figures 1B,C). Distances traveled at 7 DPI and
28 DPI did not reach significance when compared to shams
[F(2,29) = 3.23; p = 0.054; Figure 1D]. Rats at 7 DPI did
not significantly alter their duration in the center of the
open field, whereas rats at 28 DPI spent 57% less time in
the center when compared to shams (KW = 6.71; p < 0.05;
Dunn’s post hoc p < 0.05; r = 0.48; Figure 1E). Rats at
28 DPI also made 54% fewer entries into the center of the
open field when compared to shams (KW = 6.83, p < 0.05;
Dunn’s post hoc p < 0.05; r = 0.46; Figure 1F). These data
indicate that mFPI results in the expression of anxiety-like
behavior by 28 DPI.
Glutamate Neurotransmission in the BLA
Does Not Change Over 1-Month
Following dTBI
As the main sensory nuclei for anxiety-like behavior,
the BLA was examined for alterations of glutamate
neurotransmission (Pitkanen et al., 1997; Phelps and
LeDoux, 2005). BLA tissue was depolarized using a local
application of isotonic 120 mM KCl (75–150 nL) to evoke
the release of neurotransmitters. Similar volumes of KCl
were applied to the extracellular space (Supplementary
Figure S4A). KCl-evoked glutamate release in the BLA
was not significantly different between 7 DPI and 28 DPI
brain-injured rats when compared to shams (KW = 4.63
p = 0.10; Figure 2D).
Evaluation of BLA extracellular glutamate clearance
parameters was accomplished through local application of
100 µM exogenous glutamate. Peaks were amplitude-matched
to control for Michaelis-Menten kinetics, then analyzed for
glutamate clearance parameters (Supplementary Figure S4B).
Uptake rate was unaltered within the BLA at 7 DPI or 28 DPI
following injury when compared to shams [F(2,21) = 1.24;
p = 0.31; Figure 2E]. Furthermore, time taken for 80% of
maximum applied glutamate to clear (T80) was not altered
within the BLA at 7 DPI or 28 DPI when compared to shams
[F(2,21) = 0.140; p = 0.870; Figure 2F]. These data indicate that
evoked glutamate release and glutamate clearance parameters
were not influenced by mFPI at 7 DPI or 28 DPI.
Glutamate Neurotransmission in the CeA
Is Significantly Altered Over 1-Month
Following dTBI
The CeA is the main amygdaloid nucleus for regulating anxiety-
like behavior (Pitkanen et al., 1997; Phelps and LeDoux, 2005;
Frontiers in Neuroscience | www.frontiersin.org 9 January 2020 | Volume 13 | Article 1434
fnins-13-01434 January 11, 2020 Time: 11:34 # 10
Beitchman et al. TBI Induces Chronic Amygdala Dysfunction
FIGURE 3 | Acute, nuclei-specific microglial alterations occur following dTBI. Representative images of Iba1 staining in the (A) BLA and (B) CeA. Cropped
photomicrographs correspond to the highlighted square (Scale bars = 10 µm). (C) In the BLA, the number of microglia changed over time post-injury [One-way
ANOVA F (3,8) = 6.32; p < 0.05; η2 = 0.70]. (D) Branch length (µm/cell) or (E) number of microglia process endpoints per cell did not significantly change over time
[One-way ANOVA F (3,8) = 2.32; p = 0.15 and One-way ANOVA F (3,8) = 3.18; p = 0.09]. (F) In the CeA, the average number of microglia per field did not
significantly change over time [One-way ANOVA F (3,8) = 3.17; p = 0.09]. (G) Contrasting to the BLA, branch length (µm/cell) [One-way ANOVA F (3,8) = 5.27;
p < 0.05; η2 = 0.66]. (H) Number of microglia process endpoints per cell were significantly decreased at 1 DPI in comparison to sham [One-way ANOVA
F (3,8) = 7.32; p < 0.05; η2 = 0.73]. Bar graphs represents mean ± SEM. n = 3 for each group. *p < 0.05 in comparison to sham.
Tye et al., 2011). Surrounding tissues, including pre-synaptic
terminals along the BLA-CeA axis, were depolarized to
evoke the release of glutamate using local application
of 75–150 nL of 120 mM isotonic KCl. There were no
statistically significant differences in the volume of applied
KCl (Supplementary Figure S4D). Representative traces
of KCl-evoked glutamate release are shown in Figure 2G.
Glutamate released in CeA was 50% less at 28 DPI when
compared to shams [F(2,19) = 4.74; p < 0.05; Dunnett’s post
hoc p < 0.05; η2 = 0.33; Figure 2H]. Initial peak amplitude
was also significantly less at 28 DPI when compared to shams
[F(2,19) = 4.89; p < 0.05; Dunnett’s post hoc p < 0.05; η2 = 0.34;
Supplementary Figures S4C,F].
Evaluation of CeA extracellular glutamate clearance
was accomplished through local application of 100 µM
exogenous glutamate. Representative traces of resulting
glutamate peaks chosen for analysis are shown in Figure 2I.
Peaks were amplitude-matched to control for Michaelis-
Menten kinetics, then analyzed for glutamate clearance
parameters (Supplementary Figure S4E). Uptake rate was
significantly decreased at 7 DPI and 28 DPI when compared
to shams resulting in 40% and 58% decreases, respectively
[F(2,22) = 7.88; p < 0.01; Dunnett’s post hoc p < 0.05 for
7 DPI and p < 0.01 for 28 DPI; η2 = 0.42; Figure 2J].
Further, T80 of 28 DPI rats was 43% longer when compared
to shams [F(2,22) = 5.00; p < 0.05; Dunnett’s post hoc
p < 0.01; η2 = 0.31; Figure 2K]. Uptake was independent
of subsequent local applications of glutamate to the CeA [RM
F(2,21) = 8.16; p < 0.01; Figure 2L]. These data indicate
that evoked glutamate release and glutamate clearance
parameters in the CeA were significantly influenced by
mFPI over 28 DPI.
Nuclei-Specific Microglia Deramification
Manifests Acutely Along BLA-CeA Axis
Following dTBI
Images of microglia are depicted for BLA (Figure 3A)
and CeA (Figure 3B). In the BLA, microglial cell count
significantly changed as a function of time, decreasing
at 1 DPI [F(3,8) = 6.32; p < 0.05; Dunnett’s post hoc
p < 0.01 Figure 3C]. The branch length per cell (µm/cell)
did not significantly change over time [F(3,8) = 2.32;
p = 0.15; η2 = 0.70; Figure 3D]. Furthermore, the
number of microglia process endpoints per cell did
not significantly change over time [F(3,8) = 3.18;
p = 0.09; Figure 3E].
Identical analysis was performed on microglia in the CeA. The
microglial cell count per field did not significantly change over
time [F(3,8) = 3.17; p = 0.09; Figure 3F]. The branch length per
cell (µm/cell) significantly decreased at 1 DPI [F(3,8) = 7.32;
p < 0.05; η2 = 0.73; Figure 3G]. The number of microglia
process endpoints per cell was also significantly decreased at
1 DPI [F(3,8) = 5.27; p < 0.05; Dunnett’s post hoc p < 0.05;
η2 = 0.66; Figure 3H].
The same three variables were evaluated with a two-
way ANOVA to determine whether the influence of
time-post injury was similar in between the BLA and
CeA. The number of cells [F(3,16) = 7.85; p < 0.05],
endpoints [F(3,16) = 5.152; p < 0.05], and process length
[F(3,16) = 3.94; p < 0.05] all differed between regions,
indicating that TBI-induced changes in microglial morphology
at 1 and 28 DPI are region dependent (Supplementary
Figure S5). Although there is an acute microglial response
in the CeA, similar to other regions in this injury model
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FIGURE 4 | Changes in neurotransmission occur in the absence of neuropathology, astrocytosis and molecular alterations in glutamate transporters and receptor.
(A) Representative images of GFAP staining of the CeA (40× magnification; scale bar = 50 µm). (B) Pixel density analysis of GFAP staining in the CeA revealed no
significant differences following diffuse TBI [One-way ANOVA F (2,7) = 0.80; p = 0.49; n = 3–4 per group]. (C) de Olmos silver stained sections of the CeA (40×
magnification; scale bar = 50 µm). (D) Pixel density analysis of aminocupric silver stained tissue revealed that there was no difference following diffuse TBI [One-way
ANOVA F (2,6) = 0.22; p = 0.40; n = 3–4 per group]. Automated capillary western blots (in duplicate) were performed to quantify the amount of synaptic glutamate
transporters (Glt-1, GLAST) and pre-synaptic glutamate receptors (mGluR2, GluR) at 28 DPI. (E) Representative quantification of sham and injured GLAST (EAAT1)
shown individually, overlapped and with recreated western blot. (F) Levels of GLAST, Glt-1, and mGluR2 were similar to sham indicating an alternative mechanism
for observed changes in glutamate neurotransmission (n = 4–5 per group). (G) The precursor protein to BDNF was similar to sham at 28 DPI. (H) Protein levels of
mature BDNF were decreased by 43% (t4,5 = 2.07; p < 0.05; d = 1.33). (I) GluR approached significance with a 20% decrease (t4,5 = 1.854; p = 0.053). (J) TrkB
receptors were decreased by 49% (t4,5 = 3.68; p < 0.01; d = 2.41). n = 4–5 per group. Bar graphs represent mean ± SEM.
(Miremami et al., 2014; Morrison et al., 2017; Thomas et al.,
2018), and dynamics over time are region-dependent; these
data do not provide evidence that microglia have a role
in mediating glutamate neurotransmission in BLA-CeA
communication at 28 DPI.
Absence of Activated Astrocytes Over
1 Month After dTBI
Robust astrocytosis in the BLA has been previously reported
at 7 DPI and resolved by 28 DPI following experimental dTBI
using mFPI (Hoffman et al., 2017). Astrocytes are a major
contributor to glutamate neurotransmission, where activation
indicates a role in glutamate clearance from the extracellular
space. GFAP intensity was analyzed as an indicator of astrocytosis
in the CeA. There was no evidence that mFPI influenced
astrocytosis over time in the CeA [F(2,7) = 0.80; p = 0.49;
Figures 4A,B].
Absence of Overt Neuropathology in the
CeA Following dTBI
The BLA has been described as lacking overt
neuropathology at 7 DPI and 28 DPI (Hoffman et al.,
2017), however, the CeA has not been evaluated in a
model of mFPI. Using de Olmos silver stain technique,
neuropathology in the CeA was assessed at 7 DPI and
28 DPI compared to shams. No overt pathology was
identified in the CeA following mFPI [F(2,6) = 1.99;
p = 0.22; Figures 4C,D].
Alteration in Glutamate
Neurotransmission Are Independent of
Glutamate Transporters and
Pre-synaptic Receptors
Observed alterations to glutamate neurotransmission could
result from altered levels of glutamate transporters or
presynaptic metabotropic receptors (Ueda et al., 2001).
Proteins involved in glutamate transport [EAAT1 (GLAST)
EAAT2 (Glt-1)] were evaluated at 28 DPI for the BLA
and CeA. Levels of GLAST and Glt-1 were similar to
sham [GLAST (BLA t8 = 0.59 p = 0.57; CeA n = 4,
t7 = 0.75; p = 0.49; Glt-1 (BLA t7 = 0.25; p = 0.81;
CeA t6 = 0.81; p = 0.45)] (Figures 4E,F). Pre-synaptic
metabotropic glutamatergic receptors (mGluR2) levels
did not change in comparison to shams (BLA t9 = 0.09;
p = 0.93; CeA t6 = 0.51; p = 0.63) (Figure 4F), indicating
that observed changes in glutamate neurotransmission were
independent of changes in total protein levels of glutamate
transporters and mGluR2. Supplementary Figure S6 depicts
a schematic showing localization of these molecules on a
presynaptic terminal.
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BDNF and TrkB Decreased at 1-Month
Post-dTBI
As BDNF, GluR, and TrkB, have been shown to influence
presynaptic glutamate release, we tested the hypothesis that
dTBI caused decreased levels of BDNF, GluR, and TrkB in the
amygdala by 28 DPI (Kunugi et al., 2010). Protein levels of mature
BDNF were decreased by 43% (t7 = 2.07; p < 0.05; d = 1.33;
Figure 4H) (BDNF precursor was not different; Figure 4G) and
GluR approached significance with a 20% decrease (t7 = 1.854;
p = 0.053; Figure 4I). TrkB receptors were decreased by 49%
(t7 = 3.68; p > 0.01; d = 2.41; Figure 4J). These data indicate
that a single dTBI can significantly decrease BDNF and TrkB
in the amygdala by 1-month post-injury, coinciding with the
changes in evoked glutamate neurotransmission and expression
of anxiety-like behavior.
DISCUSSION
Multifactorial mental illnesses are the result of poorly understood
pathophysiology that confounds treatment approaches leading
to poor symptom control. These are the first experiments that
demonstrate dTBI initiates a cascade of molecular events in the
amygdala capable of contributing to the expression of anxiety-
like behavior. By 1-month post-injury, decreased glutamate
release and slower glutamate clearance within the CeA coincided
with the expression of anxiety-like behavior. There were no
changes in the BLA. Changes in glutamate neurotransmission
occurred despite similar protein levels of glutamate transporters,
mGluR2, and in the absence of overt neuropathology or glial
pathology. BDNF and TrkB protein levels were significantly
decreased at 28 DPI, and may be a potential target to modulate
glutamate signaling related to anxiety-like behavior. These data
indicate novel targets in the quest for understanding chronic TBI
pathophysiology associated with TBI-induced affective disorders.
Open field testing is an ethological behavioral-based test
for systematic assessment of unconditioned general exploratory
drive that can serve as an initial screening of emotional or
anxiety-like behavior, locomotor activity, and novel environment
exploration. The test can distinguish between the primal drive to
survive (aversion to light and innate predatory response) versus
exploration (enter the center area) by quantifying thigmotactic
variables, distance traveled, entrances and time in the center of
the open field as an indicator of emotionality or anxiety-like
behavior (Roth and Katz, 1979; Ennaceur, 2014). Specifically,
increased time spent alongside the walls of the open field
enclosure is indicative of a heighten aversion response and has a
high correlation factor with measures of anxiety in the elevated
plus maze in rodents (Carola et al., 2002). Characterized by
validated metrics reviewed by Gould et al. (2009), we show
evidence of late-onset anxiety-like behavior following dTBI. By
28 DPI, rats spent less time and made fewer entries into the
center of the open field when compared to shams, indicative of
anxiety-like behavior. Distance traveled between sham and brain-
injured rats did not reach significance as previously demonstrated
in Liu et al. in the same model at the same time point (Liu
et al., 2017). While Liu et al. (2017) reports dopamine axonal
damage, 25% dopamine neuronal loss and microglia activation
the nigrostriatal pathway, a minimum of 50% loss of substantia
nigral dopamine neurons is associated with movement symptoms
(Grosch et al., 2016), supporting that the loss of DA neurons is not
the primary cause of decreased locomotor activity. Morris Water
Maze testing at 15 DPI further provides evidence that injured
rats were capable of swimming a similar distance at similar swim
speed as shams indicating a behavioral response rather than
an motor deficit (Clausen et al., 2017). Repeated publications
from our lab support that non-noxious sensory stimulation of
the whiskers significantly increases freezing, guarding, evasive
behaviors and corticosterone levels at 28 DPI in comparison to
sham and 7 DPI (McNamara et al., 2010; Thomas et al., 2012),
supporting that the observed trends in decreased distance may be
associated with a heighten aversion response.
The presence of anxiety and fear-like behavior has been
reported at chronic time points in other models of TBI using
OFT, elevated plus maze and fear conditioning (Kovesdi et al.,
2011; Elder et al., 2012; Shultz et al., 2013; Almeida-Suhett et al.,
2014; Hou et al., 2017), however, the presence of affective deficits
is inconsistent and varies between experimental models, species,
behavioral paradigms and labs. For these experiments, we only
used a single behavioral test because repeated stressors (including
behavioral tests) can also result in BLA neuronal hypertrophy
and enhanced anxiety-like behavior (Vyas et al., 2004), potentially
confounding electrochemical experiments. A more thorough
independent assessment of anxiety, fear, and depressive behaviors
at 1-month post-injury are needed to determine the extent of
TBI-induced affective morbidity (Ennaceur, 2014).
Glutamatergic connections between the BLA and CeA
have been shown to regulate affective symptomatology during
neurological assessment tasks such as open field (Tye et al.,
2011; Kim et al., 2013; Janak and Tye, 2015), integrating limbic
system circuitry input from numerous regions of the brain
(Figure 5; Tye et al., 2011; Kim et al., 2013; Janak and Tye, 2015;
Tovote et al., 2015). The BLA integrates sensory afferents from
the prefrontal cortex (PFC), thalamus, and sensory association
cortex and relays this information to the ventral hippocampus,
bed nucleus of the stria terminalis (BNST), or CeA by projects
that can either promote or diminish the expression of anxiety-
like behavior (Phelps and LeDoux, 2005; Janak and Tye, 2015;
Tovote et al., 2015; Hrybouski et al., 2016). Reciprocal and
interconnections between and within nuclei of the amygdala not
shown in our diagram also modulate, in part, the BLA-CeA
circuitry and most likely influence the expression of affective
behaviors (Pitkanen et al., 1997; Phelps and LeDoux, 2005). While
the BLA-CeA circuit plays a known role in mediating affective
behaviors (Pitkanen et al., 1997; Phelps and LeDoux, 2005); the
functional, structural, and molecular components underlying the
development after TBI have never been evaluated.
For real-time recordings of extracellular neurotransmission,
in vivo amperometry coupled with glutamate selective
multielectrode arrays were utilized for their excellent spatial
and temporal resolution and the presence of sentinel channels
to verify glutamate specificity. Localized KCl administration
induced non-specific neurotransmitter release in which
glutamate-sensitive MEA’s measured synaptic glutamate
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FIGURE 5 | Anxiety-like behavior coincides with altered glutamate neurotransmission in amygdala circuitry. Simplified circuitry of the rat’s efferent and afferent
projections of the amygdala that are considered to play important roles in the regulation of anxiety-like behavior. Glutamatergic projections enter the BLA from the
PFC and thalamus and carry sensory information of the overall anxious state of the rat. The BLA interprets this information and sends efferent outputs to either
promote (+) or inhibit (–) the display of anxiety-like behavior. Activation of BLA-CeA circuitry has shown to mediate anxiolytic behavior. Boxes summarize findings.
PFC, prefrontal cortex; BLA, basolateral amygdala; CeA, central nucleus of the amygdala; BNST, bed nucleus stria terminalis; VTA, ventral tegmental area. Anatomy
modified from Paxinos and Watson, 2007.
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overflow. In the BLA, no significant changes were detected,
however, in the CeA glutamate release was decreased by
28 DPI compared to uninjured shams. Reduced glutamate
release indicates less stores available for potential neuronal
communication between those located in presynaptic neurons,
interneurons, and astrocytic processes. The second peak within
the biphasic profile of KCl-evoked glutamate release (Figure 2G)
provides evidence that glial transmission could be contributing
to glutamate overflow whereas the first peak is thought to
primarily be the response of presynaptic neurons (Parpura et al.,
1994; Larter and Craig, 2005). While the amplitude of the first
peaks was also significantly decreased at 28 DPI compared to
shams (Supplementary Figures S4C,F), area under the curve
was used to evaluate glutamate overflow. Changes in glutamate
overflow could arise from impaired vesicular loading (Watt
et al., 2000) or secondary to inhibitory GABA-ergic modulation
(Jacob et al., 2008). We did not find an injury-induced change
in the protein level of mGluR2 in the CeA, indicating that total
mGluR2 is not predictive of changes in presynaptic glutamate
release. We did not observe astrocytosis or perturbation of
microglia at 28 DPI. Decreased BDNF/TrkB/GluR protein levels
can reduce presynaptic glutamate release, however, localization,
cell type, and functional studies are necessary to identify their
role (Numakawa et al., 2009; Meis et al., 2012). As the majority
of the CeA is GABAergic in nature, the release of glutamate
is hypothesized to be from pre-synaptic neurons originating
in the BLA. As Tye et al. (2011) indicates, stimulation of these
synapses produces a decrease in the expression of anxiety
behavior (McDonald, 1982; Carlsen, 1988; Smith and Pare,
1994). Therefore, decreased glutamate release in the CeA may
be indicative of a permissive effect along BLA-CeA circuit such
that the ability to suppress an adverse, anxiety-like response
is diminished, as indicated by the concurrent expression of
anxiety-like behavior. Thus, while novel in TBI, our results
parallel the consensus that dysregulation of the CeA may be
concomitant with the expression of affective conditions (Kalin
et al., 2004; Etkin et al., 2009).
Locally applied glutamate to the BLA and CeA allowed us
to calculate glutamate clearance from the extracellular space,
primarily mediated by glutamate transporters (Glt-1 and GLAST)
located on adjacent astrocytes in the rodent (Danbolt, 2001).
The affinity of glutamate transporters can be evaluated using
glutamate uptake rate, whereas the number of membrane bound
transporters is estimated using T80 (Thomas et al., 2017).
In the BLA, glutamate clearance parameters did not change
as a function of injury over time. In the CeA, the uptake
rate was significantly slower at 7 DPI and 28 DPI while
glutamate took significantly longer to clear (T80) by 28 DPI.
For calculations of glutamate parameters, three consecutive
peaks in each region were analyzed. The consecutive peaks
were reproducible, and the uptake rate remained significantly
different regardless of the repeated applications, confirming that
observed alterations to glutamate clearance are not caused by
immediate tissue compensation. Changes in glutamate clearance
were also not due to changes in the protein levels of glutamate
transporters. Slower glutamate clearance could also be caused by
surface expression, post-translational modifications, or adaption
of glia and adjacent cells (Maragakis and Rothstein, 2004;
Hinzman et al., 2012).
No significant alterations were detected in the BLA in
anesthetized rats in this study, although studies using focal TBI
models indicate that BLA circuitry becomes weakened through
altered neuronal excitability, changes in N-methyl-D-aspartate
(NMDA) receptors, and changes to GABAergic production
proteins (GAD-67), all of which may provide compensatory
responses that primarily influence glutamate release in the
CeA (Reger et al., 2012; Palmer et al., 2016; Hoffman et al.,
2017). Previously, we reported increased neuropathology in
the somatosensory cortex and thalamus following dTBI, which
could also alter sensory input into the BLA (Lisembee and
Lifshitz, 2008; Thomas et al., 2018). Recent publications have
also indicated subacute metabolic, and chronic metabolic and
structural changes mapped directly to the CeA, and impairments
in extinction of contextual fear differences at a chronic time
point after experimental TBI (Zhao et al., 2018; Jaiswal et al.,
2019; Kulkarni et al., 2019). In accordance with the data in
this manuscript, these reports specifically identify the CeA as
a vulnerable anatomic locus for future investigations, where
FDA approved drugs with affinities for identified targets can be
evaluated for new indications on their influence on glutamate
signaling in anxiety-like behavior.
No significant differences were measured between 7 DPI and
28 DPI for both OFT and glutamate neurotransmission, however,
a trend toward significance was observed over time post-injury.
We’ve previously reported increased dendritic branching of both
pyramidal and stellate glutamatergic neurons in the BLA at
1 DPI, continually changing and persisting out to 28 DPI,
with evidence of increased distal branching at 28 DPI in
comparison to sham (Hoffman et al., 2017). This continuum of
increased neuromorphic connection is indicative of increased
communication within and beyond the BLA, and could
differentially influence behavior and glutamatergic recordings,
contributing to less robust responses at 7 DPI. We have
previously published a different time course of morphological
changes in the ventral posteromedial nucleus of the thalamus
(VPM), the thalamic relay of the somatosensory whisker barrel
circuit (Thomas et al., 2018). The time course of events in the
BLA are different in comparison to the VPM, where dendritic
loss peaks and 7 DPI and significantly increases by 28 DPI,
coinciding with increased neuropathology (silver stain), glial
activation, evoked-glutamate release, and the manifestation of
hypersensitivity to whisker stimulation (McNamara et al., 2010;
Thomas et al., 2012, 2018). The same archival histology for
neuropathology and microglia has also been published for the
somatosensory barrel fields of the whisker circuit (Lisembee
and Lifshitz, 2008; Cao et al., 2012; Morrison et al., 2017)
and replicated in mouse mFPI (Rowe et al., 2019). Together,
these data indicate that TBI-induced circuit pathophysiology is
dependent on time, region, and likely, circuit connectivity.
Microglia and astrocytes can directly and indirectly contribute
to the homeostasis of excitatory neural circuitry through synaptic
remodeling, release of soluble molecules, microglia-astrocyte
interaction, and scaling excitatory-inhibitory signaling (reviewed
in Henstridge et al., 2019). Specifically, activated microglia can
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promote neuropathology and synaptic loss that can directly
influence glutamate neurotransmission. Morphological analysis
of microglia in the BLA and CeA nuclei were evaluated to
identify a potential role for microglia in TBI-induced changes in
glutamate neurotransmission. At 28 DPI, microglia morphology
indicated a ramified state that may not contribute to the changes
measured in glutamate neurotransmission. However, nuclei-
dependent neuroinflammatory response did preceded changes
in glutamatergic neurotransmission along the BLA-CeA circuit.
De-ramified microglia were identified in the CeA, but not
the BLA, at 1 DPI. In the CeA, microglial cell counts did
not change over time, while the summed process length and
number of microglial process endpoints per cell were found
to be significantly decreased at 1 DPI. These data suggest that
microglia become de-ramified in the CeA early and recover
to sham levels by 7 DPI, indicative of an acute inflammatory
response after injury (Ramlackhansingh et al., 2011). Targeted
studies mediating acutely activated microglia are necessary
to determine whether early activation influences long-term
glutamate neurotransmission.
Subsequently, we analyzed CeA neuropathology to determine
if axonal injury and neurodegeneration was coincident
with changes in glutamate neurotransmission. However,
in accordance with previous results published for the BLA
(Hoffman et al., 2017), silver staining had no evidence of
neuronal or axonal injury.
Glutamate neurotransmission is primarily mediated by
glutamate transporters located on astrocytes. Changes in
overflow of glutamate from the tripartite synapse can be
attributed to altered astrocytic function. While astrocytes have
been implicated in anxiety symptoms, this role is unclear.
Studies report that GFAP levels can mediate expression of
glutamate transporters, such that low levels of GFAP are
associated with mood disorders, activation of astrocytes influence
neurotransmission, and microglial activation triggers astrocyte-
mediated modulation of excitatory neurotransmission (Pascual
et al., 2012). In evaluating GFAP immunohistochemistry,
increased levels of GFAP can be interpreted as a presence of
activated astrocytes or increased number of astrocytes, whereas
decreased levels can indicate a downregulation of GFAP and/or
reduced number of astrocyte (reviewed in Hughes et al.,
2004; Rajkowska and Miguel-Hidalgo, 2007; Zhou et al., 2019).
Analysis of GFAP density in the CeA revealed no differences
over time post-injury, in contrast to our previous work in
the BLA, where morphology and increased GFAP staining
indicated activated astrocytes at 7 DPI (Hoffman et al., 2017).
Furthermore, glutamate transporter protein levels were not
decreased at 28 DPI, negating a GFAP expression level/glutamate
transporter interaction. These data do not support a substantial
role for astrocytes in the changes in anxiety-like behavior and
glutamate neurotransmission reported in this manuscript. Taking
into consideration the microglia results, it is also unlikely that
microglia-astrocyte interactions mediate these changes.
Chronologically, dTBI initiates an immediate release of
glutamate, a stress response that includes increased circulating
corticosterone levels, and a cascade of inflammatory cytokines
that could mediate early CeA microglial activation through
ionotropic and metabotropic glutamate receptors and
glucocorticoid receptors (Murugan et al., 2013; Madalena
and Lerch, 2017). We have previously reported a significant
decrease in basal plasma corticosterone levels and a blunted
stress response at 56 DPI, indicating chronic dysregulation of
the HPA axis in this dTBI model (Rowe et al., 2016). Chronic
dysregulation of corticosterone in response to stress has also
been supported in other TBI models at both earlier and later
time points (Griesbach et al., 2011, 2012). The central amygdala
mediates the HPA axis response to stress, where changes
in circulating corticosterone levels, GR, BDNF, and Trk-B
receptor expression have been implicated in the pathology of
affective disorders (anxiety-like behavior and posttraumatic
stress disorder-like phenotypes) in addition to presynaptic
glutamate signaling (Numakawa et al., 2009; Kunugi et al.,
2010; Tejeda and Diaz-Guerra, 2017). Further evaluation is
necessary to determine whether a role exists for corticosterone
dysregulation and corticosterone regulated receptors in the
development of anxiety-like behavior and changes in glutamate
neurotransmission over time following dTBI.
Clinically, it is difficult to differentiate the initiating insult
for patients experiencing affective symptoms, such as anxiety
or PTSD, as similar pathophysiology exists between dTBI and
chronic stress (Owens et al., 2008; French, 2010; MacGregor et al.,
2011; DePalma and Hoffman, 2016). This study provides a novel
link between dTBI-induced late-onset anxiety-like behavior
and altered glutamate neurotransmission within the CeA, that
parallels clinical studies implicating dysfunctional amygdala
processing and the expression of affective symptomatology
post-injury (Etkin and Wager, 2007; Koenigs and Grafman, 2009;
Depue et al., 2014; Buchsbaum et al., 2015; Hrybouski et al.,
2016; Stevens et al., 2016). Decreased BDNF/TrkB protein levels
implicate one pathway by which dTBI can influence glutamate
neurotransmission and thereby anxiety-like symptoms.
Identification of common pathways for the development
of TBI-induced and non-TBI-induced affective disorders are
instrumental in treatment of symptoms, rehabilitation guidelines,
and implementation of novel clinical approaches.
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FIGURE S1 | Schematic of glutamate sensitive MEA. Ascorbic acid and other
aromatic compounds are repelled from the MEA due to the electroplated
1,3-phenylenediamine (mPD) exclusion layer. Glutamate sensing (bottom pair) and
sentinel (top pair) recording sites are coated with BSA and glutaraldehyde.
Glutamate oxidase is added to signal sites only to convert glutamate to
α-ketoglutarate and peroxide. Peroxide is oxidized on the platinum recording sites
as a result of an applied potential of 0.7 V vs. Ag/AgCl reference electrode, thereby
producing a current that is correlated with the concentration of glutamate present.
Sentinel sites (top pair) are unable to record glutamate due to the lack of glutamate
oxidase. Top left corner depicts an MEA. Schematic and MEA are not to scale.
FIGURE S2 | Representative confirmation of MEA placement. Following
amperometric experiments, brains were harvested and fixed for MEA placement.
Brains were cut coronally at 40 µm. Here, a representative image of MEA
placement into the anatomical ventral lateral hemisphere of the rat is shown. The
black arrows indicate the outer track (BLA) and the inner track (CeA).
FIGURE S3 | Skeletal Analysis Technique. Individual steps for skeleton analysis of
microglia morphologies of Iba1 stained tissue. Original photomicrographs were
subjected to a series of uniform ImageJ plugin protocols prior to conversion to
binary images which were then skeletonized. An overlay of a resulting skeletonized
image (in green) and original photomicrograph shows the relationship between
skeleton and photomicrograph. All skeleton analysis was completed on full sized
photomicrographs (40× magnification; scale bar = 10 µm).
FIGURE S4 | Controls for applied solutions in amperometric recordings.
Anesthetized in vivo amperometric recordings of glutamate neurotransmission
were conducted in sham, 7 DPI, and 28 DPI rats in the BLA (A/P: −2.4 M/L ± 5.1
D/V −8.0) or CeA (A/P: −2.4 M/L ± 3.9 D/V −8.0). Local applications of 120 mM
potassium chloride solution (KCl) were made to depolarize surrounding neurons.
No differences in the volume locally applied was observed between sham and
brain-injured rats in the (A) BLA [One-way ANOVA F(2,24) = 0.19; p = 0.83;
n = 7–9] or (D) CeA [One-way ANOVA F(2,19) = 0.68; p = 0.52; n = 6–9]. Local
applications of exogenous 100 µM were made to measure extracellular glutamate
clearance. All applied peaks were amplitude matched prior to analysis in the (B)
BLA [One-way ANOVA F(2,21) = 0.23; p = 0.79; n = 6–10] and (E) CeA[One-way
ANOVA F(2,22) = 1.05; p = 0.37; n = 7–10] to control for Michaelis Menten
kinetics. The maximum amplitude for evoked glutamate release in the BLA did not
differ (C) [One-way ANOVA F(2,24) = 0.11; p = 0.90; n = 7–9], but was
significantly decreased in the CeA at 28 DPI in comparison to sham (F) [One-way
ANOVA F(2,19) = 4.89; p < 0.05; n = 6–9]. Bar graphs represent the
mean ± SEM.
FIGURE S5 | BLA and CeA microglia respond differently to dTBI over time.
Microglial morphology changes as a function of time post-injury and region. (A)
Microglial cell counts were different than sham after 1, 7, and 28 DPI in the BLA
[Two-way ANOVA F(3,16) = 7.85; p < 0.05] (B). The number of microglial process
endpoints/cell was lower than sham after mFPI in the CeA [(3,16) = 5.152;
p < 0.05]. (C) The summed process length/cell were lower than sham after mFPI
in the CeA [F(3,16) = 3.94; p < 0.05]. Bar graphs represent mean ± SEM,
n = 3/group. ∗p < 0.05 in comparison to sham. +p < 0.05 in comparison to 1 DPI.
FIGURE S6 | Representation of glutamatergic targets for protein quantification
studies. Representation of a glutamatergic synapse and the proteins that regulate
glutamate neurotransmission. Diagram modified from Thomas et al. (2012).
TABLE S1 | Optimization parameters for antibodies and protein concentrations.
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